Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376852632> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4376852632 endingPage "41" @default.
- W4376852632 startingPage "38" @default.
- W4376852632 abstract "One of the most relevant and promising areas in the world of oncogynecology, enabling deeper understanding of the etiology and pathogenesis of malignant growth, to study the processes occurring in women, is the study of molecular biological markers, characterizing apoptosis, cell proliferation and angiogenesis. To increase the effectiveness of combined treatment of the patients with endometrial cancer I−II (Т1−2N0M0) stages and prevent the occurrence of local recurrences as well as distant metastases on the basis of investigating the molecular biological features of tumor and their prognostic value, a study based on clinical observations of 125 women was performed. Their treatment included surgery and a postoperative course of remote radiation therapy. The strategy of adjuvant therapy was designed according to the definition of the group of increased risk of cancer recurrence in the patients with negative receptor status (ER, PR) based on the degree of differentiation of endometrial adenocarcinoma (G), depth of tumor invasion into the myometrium and its location in the cavity as well as the level of expression of molecular biological markers (VEGF, Bcl−2, Ki−67). To select the tactics of further treatment, each of the indices was evaluated in points on a scale. Next, the intervals of the total value of S points were set, depending on which the program of combined adjuvant therapy was chosen: up to 6 points the contact radiation therapy was performed, 7−12 points − there was applied a remote in the postoperative period; 13 points − after remote and contact radiation, six more cycles of chemotherapy were added. Analysis of the research results showed that the developed method of combined treatment of patients with endometrial cancer I−II (Т1−2N0M0) stages allows the personalization of the protocol of adjuvant therapy and recurrence prevention. Key words: endometrial cancer, molecular biological markers, treatment results, adjuvant therapy." @default.
- W4376852632 created "2023-05-18" @default.
- W4376852632 creator A5014363177 @default.
- W4376852632 creator A5022584993 @default.
- W4376852632 creator A5030807916 @default.
- W4376852632 creator A5087807970 @default.
- W4376852632 date "2020-12-24" @default.
- W4376852632 modified "2023-10-15" @default.
- W4376852632 title "COMBINED TREATMENT OF PATIENTS WITH ENDOMETRIAL CANCER I-II (Т1-2N0M0) TAKING INTO ACCOUNT THE LEVEL OF EXPRESSION OF MOLECULAR BIOLOGICAL TUMOR MARKERS" @default.
- W4376852632 cites W2297208068 @default.
- W4376852632 cites W2345388577 @default.
- W4376852632 cites W2610293438 @default.
- W4376852632 cites W2809617911 @default.
- W4376852632 cites W2980159020 @default.
- W4376852632 doi "https://doi.org/10.37436/2308-5274-2020-4-7" @default.
- W4376852632 hasPublicationYear "2020" @default.
- W4376852632 type Work @default.
- W4376852632 citedByCount "0" @default.
- W4376852632 crossrefType "journal-article" @default.
- W4376852632 hasAuthorship W4376852632A5014363177 @default.
- W4376852632 hasAuthorship W4376852632A5022584993 @default.
- W4376852632 hasAuthorship W4376852632A5030807916 @default.
- W4376852632 hasAuthorship W4376852632A5087807970 @default.
- W4376852632 hasBestOaLocation W43768526321 @default.
- W4376852632 hasConcept C121608353 @default.
- W4376852632 hasConcept C126322002 @default.
- W4376852632 hasConcept C143998085 @default.
- W4376852632 hasConcept C2777088508 @default.
- W4376852632 hasConcept C2777982462 @default.
- W4376852632 hasConcept C2780394083 @default.
- W4376852632 hasConcept C509974204 @default.
- W4376852632 hasConcept C71924100 @default.
- W4376852632 hasConceptScore W4376852632C121608353 @default.
- W4376852632 hasConceptScore W4376852632C126322002 @default.
- W4376852632 hasConceptScore W4376852632C143998085 @default.
- W4376852632 hasConceptScore W4376852632C2777088508 @default.
- W4376852632 hasConceptScore W4376852632C2777982462 @default.
- W4376852632 hasConceptScore W4376852632C2780394083 @default.
- W4376852632 hasConceptScore W4376852632C509974204 @default.
- W4376852632 hasConceptScore W4376852632C71924100 @default.
- W4376852632 hasIssue "4(104)" @default.
- W4376852632 hasLocation W43768526321 @default.
- W4376852632 hasOpenAccess W4376852632 @default.
- W4376852632 hasPrimaryLocation W43768526321 @default.
- W4376852632 hasRelatedWork W1758517966 @default.
- W4376852632 hasRelatedWork W2011002300 @default.
- W4376852632 hasRelatedWork W2397211250 @default.
- W4376852632 hasRelatedWork W2955721281 @default.
- W4376852632 hasRelatedWork W3010248220 @default.
- W4376852632 hasRelatedWork W3157935231 @default.
- W4376852632 hasRelatedWork W3198485845 @default.
- W4376852632 hasRelatedWork W4250305301 @default.
- W4376852632 hasRelatedWork W4299638319 @default.
- W4376852632 hasRelatedWork W4363647753 @default.
- W4376852632 isParatext "false" @default.
- W4376852632 isRetracted "false" @default.
- W4376852632 workType "article" @default.